| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1414821B1 Tricyclic epoxides |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/16/2006 | EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | CN1820008A Substituted quinolin-4-ylamine analogues |
| 08/16/2006 | CN1820000A A method for the preparation of enantiomerically pure mirtazapine |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269817C Dehalogeno compounds |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091351 Vanadium compounds for treating cancer |
| 08/15/2006 | US7091345 Tyrosine kinase inhibitor; anticancer agents; antiproliferative agents; antiinflammatory agents |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist |
| 08/15/2006 | US7091214 Immonomoderators; viricides; anticancer agents |
| 08/15/2006 | US7091211 3-(aryl or heteroaryl)-4-((spiropiperidin-1-yl)alkyl)cyclopentyl compounds and stereisomers, used for prevention of lymphadenopathy associated virus infection, and delaying the onset of aquired immune deficiency syndrome |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | US7091198 2,5-disubstituted pyrimidine derivatives |
| 08/15/2006 | CA2258752C Naphthyridines which affect il-4 and g-csf |
| 08/15/2006 | CA2161783C Ampa antagonists and a method of treatment therewith |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083908A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 08/10/2006 | WO2006083440A2 Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082492A1 Azabicyclo derivatives as anti-inflammatory agents |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006069193A3 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 08/10/2006 | WO2006061791A3 Novel diazabicyclononene derivative |
| 08/10/2006 | WO2006058628A3 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
| 08/10/2006 | WO2005079195A3 Pyrazolopyridines and analogs thereof |
| 08/10/2006 | WO2005047279A8 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 08/10/2006 | US20060178514 Novel benzylamine derivatives as CETP inhibitors |
| 08/10/2006 | US20060178408 Phosphodiesterases (PDE); for treating respiratory, nervous system, cardiovascular, inflammatory and allergic diseases, disorders and conditions as well as wounds |
| 08/10/2006 | US20060178391 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 08/10/2006 | US20060178390 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| 08/10/2006 | US20060178381 GlyT-1 inhibitors; CNS disorders such as psychoses, dysfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease; (2-isobutoxy-5-methanesulfonyl-phenyl)-(3-trifluoromethyl-5,7-dihydro-pyrrolo[3,4-b]pyridin-6-yl)-methanone and pyrrolo[3,4-c]pyridines |
| 08/10/2006 | US20060178378 Novel kinase inhibitors |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |
| 08/10/2006 | US20060178358 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | CA2596973A1 Raf inhibitor compounds and methods |
| 08/10/2006 | CA2596754A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its uses for the treatment of inflammatory, autoimmune and proliferative diseases and disorders |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2596358A1 Aqueous gel formulations containing 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 08/10/2006 | CA2594674A1 Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
| 08/09/2006 | EP1687318A2 New coupling agents for peptide synthesis |
| 08/09/2006 | EP1687311A1 Novel compounds |
| 08/09/2006 | EP1687307A2 Substituted imidazo ring systems and methods |
| 08/09/2006 | EP1687306A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 08/09/2006 | EP1687305A1 1h-imidazoquinoline derivatives as protein kinase inhibitors |
| 08/09/2006 | EP1687304A1 Substituted quinolines for the treatment of cancer |
| 08/09/2006 | EP1687296A1 Antibacterial aminoquinazolidinedione derivatives |
| 08/09/2006 | EP1687294A2 Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 08/09/2006 | EP1687293A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/09/2006 | EP1687002A1 Fused heterocyclic compounds |
| 08/09/2006 | EP1686999A1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 08/09/2006 | EP1686996A1 Quinazolinone compounds with reduced bioaccumulation |
| 08/09/2006 | EP1686992A2 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 08/09/2006 | EP1686856A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides |
| 08/09/2006 | EP1511748B1 8-fluorimidazo(1,2-a)pyridine derivatives as ligands for gaba receptors |
| 08/09/2006 | EP1455779B1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1399442B1 Cak inhibitors and uses thereof |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
| 08/09/2006 | EP1315491B1 Use of substituted pyrazoles for the manufacture of a medicament for the treatment of allergies |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | CN1816543A Indole derivatives with apoptosis-inducing effect |
| 08/09/2006 | CN1816541A Substituted-1-phthalazinamines as vr-1 antagonists |
| 08/09/2006 | CN1816532A Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 08/09/2006 | CN1816523A N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/09/2006 | CN1268692C Functionalized perylene tetracarboxylic acid diimides |
| 08/08/2006 | US7087757 Phenyl-substituted imidazopyridines |
| 08/08/2006 | US7087756 6-(4-Dimethylaminomethyl-phenyl)-3-phenyl-5H-isoxazolo[4,5-c]pyridine-4-one and 6-[4-(2-Methoxy-ethoxymethyl)-phenyl]-5-methyl-3-phenyl-5H-isoxazolo[4,5-c]pyridin-4-one; use treating Parkinson's disease |
| 08/08/2006 | US7087755 2-substituted pyridine-4-boronic acids created by reacting a metallated pyridine with an electrophile; useful in combinatorial approaches by virtue of their boronic moiety and at least one additional functional group |
| 08/08/2006 | US7087750 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 08/08/2006 | US7087744 Comprises azamethine/nucleic acid complex; reverse transcription; transferases |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087618 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087607 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |